Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Scilex Holding Company Warrant (SCLXW)
Biological Products, (no Disgnostic Substances)
Scilex Holding Co is engaged in the development and commercialization of non-opioid pain management products. The company's lead product ZTlido.
960 SAN ANTONIO ROAD
PALO ALTO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
11/11/2022
Market Cap
241,607,285
Shares Outstanding
13,180,000
Weighted SO
N/A
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
1.2260
Last Div
0.0000
Range
0.2929-0.3592
Chg
0.0023
Avg Vol
N/A
Mkt Cap
241607285
Exch
NASDAQ
Country
US
Phone
650 516 4310
DCF Diff
N/A
DCF
0.0000
Div Yield
0.0000
P/S
4.6404
EV Multiple
-3.1816
P/FV
-0.6885
Div Yield %
0.0000
P/E
-1.2433
PEG
-0.0557
Payout
0.0000
Current Ratio
0.1974
Quick Ratio
0.1853
Cash Ratio
0.0270
DSO
272.8830
DIO
61.6018
Op Cycle
334.4847
DPO
837.6678
CCC
-503.1830
Gross Margin
0.6418
Op Margin
-1.9502
Pretax Margin
-2.3386
Net Margin
-2.3388
Eff Tax Rate
-0.0006
ROA
-1.1372
ROE
0.6426
ROCE
0.6569
NI/EBT
1.0001
EBT/EBIT
1.1992
EBIT/Rev
-1.9502
Debt Ratio
0.7458
D/E
-0.3631
LT Debt/Cap
-0.0089
Total Debt/Cap
-0.5702
Int Coverage
-45.7692
CF/Debt
-0.0455
Equity Multi
-0.4869
Rec Turnover
1.3376
Pay Turnover
0.4357
Inv Turnover
5.9252
FA Turnover
15.4414
Asset Turnover
0.4862
OCF/Share
-0.0295
FCF/Share
-0.0346
Cash/Share
0.0573
OCF/Sales
-0.0698
FCF/OCF
1.1725
CF Coverage
-0.0455
ST Coverage
-0.0467
CapEx Coverage
-5.7956
Div&CapEx Cov
-5.7956
P/BV
-0.6885
P/B
-0.6885
P/S
4.6404
P/E
-1.2433
P/FCF
-56.6812
P/OCF
-41.6487
P/CF
-41.6487
PEG
-0.0557
P/S
4.6404
EV Multiple
-3.1816
P/FV
-0.6885
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
1.05M Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
0.00 Shares Bought (0.00 %)
76.95M Shares Sold (100.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2023 | 2024 | 2024 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 5.26M | ▲ 5.89M | ▲ 7.83M | ▲ 11.92M | ▲ 13.46M | ▼ 10.88M | ▼ |
Cost Of Revenue | 1.45M | ▼ 537.25K | ▲ 908.50K | ▲ 4.51M | ▲ 5.56M | ▼ 4.87M | ▼ |
Gross Profit | 3.81M | ▲ 5.35M | ▲ 6.92M | ▲ 7.41M | ▲ 7.91M | ▼ 6.01M | ▼ |
Gross Profit Ratio | 0.72 | ▲ 0.91 | ▼ 0.88 | ▼ 0.62 | ▼ 0.59 | ▼ 0.55 | ▼ |
Research And Development Expenses | 21.38M | ▼ 2.49M | ▼ 2.30M | ▲ 2.60M | ▲ 2.73M | ▲ 3.11M | ▼ |
General And Administrative Expenses | 16.17M | ▼ 10.74M | ▲ 12.65M | ▲ 16.22M | ▼ 0.00 | 0.00 | |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | ▲ 7.30M | ▼ 0.00 | 0.00 | |
Selling General And Administrative Expenses | 16.17M | ▼ 10.74M | ▲ 12.65M | ▲ 23.52M | ▼ 23.51M | ▲ 29.27M | ▼ |
Other Expenses | -76.03M | ▲ -27.40M | ▼ -34.03M | ▲ 980.50K | ▼ -2.99M | ▼ -3.91M | ▼ |
Operating Expenses | -38.48M | ▲ -14.17M | ▼ -19.08M | ▲ 27.15M | ▼ 26.25M | ▲ 32.38M | ▼ |
Cost And Expenses | 39.93M | ▼ 14.70M | ▲ 16.79M | ▲ 31.66M | ▲ 31.80M | ▲ 37.25M | ▼ |
Interest Income | 0.00 | 0.00 | 0.00 | ▲ 1.01M | ▼ -6.00K | ▲ 0.00 | |
Interest Expense | 4.22M | ▼ 3.28M | ▲ 9.94M | ▼ 1.01M | ▼ 551.00K | ▼ 531.00K | ▼ |
Depreciation And Amortization | 928.25K | ▲ 934.50K | 934.50K | ▲ 1.04M | ▼ 1.03M | ▼ 1.03M | ▼ |
Ebitda | -39.50M | ▲ -7.68M | ▼ -11.23M | ▼ -18.71M | ▲ -17.31M | ▼ -25.34M | ▼ |
Ebitda Ratio | -7.51 | ▲ -1.30 | ▼ -1.43 | ▼ -1.57 | ▲ -1.29 | ▼ -2.33 | ▼ |
Operating Income | -34.67M | ▲ -8.81M | ▼ -12.16M | ▼ -19.74M | ▲ -18.34M | ▼ -26.37M | ▼ |
Operating Income Ratio | -6.59 | ▲ -1.50 | ▼ -1.55 | ▼ -1.66 | ▲ -1.36 | ▼ -2.42 | ▼ |
Total Other Income Expenses Net | -9.97M | ▲ -3.08M | ▼ -9.94M | ▲ 2.91M | ▼ -3.05M | ▲ 1.99M | ▼ |
Income Before Tax | -44.65M | ▲ -11.89M | ▼ -22.10M | ▲ -17.84M | ▼ -21.39M | ▼ -24.38M | ▼ |
Income Before Tax Ratio | -8.49 | ▲ -2.02 | ▼ -2.82 | ▲ -1.50 | ▼ -1.59 | ▼ -2.24 | ▼ |
Income Tax Expense | 500.00 | ▼ -13.25K | ▲ 1.25K | ▲ 40.00K | ▼ 8.00K | ▼ -1.00 | ▼ |
Net Income | -44.65M | ▲ -11.88M | ▼ -22.11M | ▲ -17.88M | ▼ -21.40M | ▼ -24.38M | ▼ |
Net Income Ratio | -8.49 | ▲ -2.02 | ▼ -2.82 | ▲ -1.50 | ▼ -1.59 | ▼ -2.24 | ▼ |
Eps | -0.32 | ▲ -0.08 | ▼ -0.16 | -0.16 | ▼ -0.21 | ▼ -0.24 | ▼ |
Eps Diluted | -0.32 | ▲ -0.08 | ▼ -0.16 | -0.16 | ▼ -0.21 | ▼ -0.24 | ▼ |
Weighted Average Shs Out | 141.10M | 141.10M | 141.10M | ▼ 112.42M | ▼ 100.02M | ▲ 102.41M | ▼ |
Weighted Average Shs Out Dil | 141.10M | 141.10M | 141.10M | ▼ 112.42M | ▼ 100.02M | ▲ 102.41M | ▼ |